GLP1 Protocol
quizGLP-1 Q&A

Coming Off a GLP-1

When the injections stop, the appetite signals come back. Here's a realistic week-by-week and month-by-month picture of what changes — and what you can do to hold as much of your loss as possible.

The short answer

Appetite returns within days to a few weeks of stopping a GLP-1. Food noise — the constant background thinking about eating — typically comes back first. Weight regain usually begins within 1-3 months and accelerates from there. STEP 1 trial data showed that semaglutide patients regained about two-thirds of their lost weight within one year of stopping. The single biggest variable in how much you regain is how well your nutrition, protein intake, and movement habits hold after the medication is gone.

What the research says

The STEP 1 extension trial is the most-cited dataset on what happens after stopping. Adults who lost a mean of 17.3% of body weight on semaglutide 2.4 mg over 68 weeks regained 11.6 percentage points of body weight in the year after discontinuation. Net loss at week 120 was about 5.6% from baseline. Roughly 48% still held at least a 5% loss one year off treatment, but the trajectory across the group was steady regain.

The SURMOUNT-4 trial on tirzepatide showed a similar pattern. Patients who were switched from active drug to placebo regained roughly half of their lost weight over the following year, while patients who stayed on tirzepatide continued losing or held steady. The biological story is consistent across both molecules: removing the GLP-1 (or GLP-1 plus GIP) signal allows appetite, satiety latency, and gastric emptying to return toward baseline, and body weight follows.

The timeline within the first weeks off medication is less well documented in trials but well described in clinical experience. Most people notice food noise returning within 1-2 weeks. Hunger between meals typically intensifies by weeks 3-4. Measurable weight regain often begins by month 2-3, though early changes can be masked by fluid shifts. The pattern is gradual at first, then more pronounced if eating patterns shift back to pre-treatment habits.

Half-life matters here too. Semaglutide and tirzepatide both have half-lives of roughly one week. That means the drug is essentially gone from your system about 5-6 weeks after the last dose, with a clinically meaningful taper of effect over the first 2-3 weeks. There is no need to take a final dose to "wash out" — the drug's own pharmacokinetics handle that.

What this means for you

If you are stopping because you finished a planned course, the most protective thing you can do in the first 8 weeks is keep your protein intake high (1.2-1.6 g/kg ideal body weight), keep moving (especially resistance training to preserve lean mass), and pay attention to portion creep. The first 1-3 months are the window where habits set in or unravel.

If you are stopping because of cost, side effects, or another constraint, talk to your provider about whether a lower maintenance dose is realistic. Many people do well on a step-down dose — say, 1.0 mg semaglutide instead of 2.4 mg — that costs less and is easier to tolerate while still suppressing enough of the regain biology to be useful.

If you are stopping to attempt pregnancy, the 2-month washout in the FDA labels for semaglutide and tirzepatide is the load-bearing timeline. Plan accordingly — that's not a stretch goal, it's the recommendation.

And if you find weight coming back faster than you expected, that is not a personal failure. It is what the biology does. The drug was doing real work; when it stops, the work stops. Many people restart at some point, and the data on restarting after a break is broadly reassuring — most regain responsiveness without issue.

Key takeaways

schedule

Plan for a real timeline, not a clean stop

Appetite returns in days. Weight regain typically starts month 2-3. Treat the first 8 weeks as the critical habit-locking window.

fitness_center

Protein and strength are non-negotiable

1.2-1.6 g/kg ideal body weight of protein plus resistance training preserves the lean mass that protects your resting metabolic rate.

trending_down

A taper beats an abrupt stop

If cost or side effects are the driver, a lower maintenance dose may hold more of your loss than stopping cold turkey. Talk to your prescriber.

Common questions

Common Concerns

How quickly will my appetite come back?expand_more
Most people notice food noise returning within 1-2 weeks of stopping. Hunger between meals typically intensifies by weeks 3-4. The drug is essentially cleared from your system about 5-6 weeks after the last dose, given the roughly one-week half-life of both semaglutide and tirzepatide.
How much weight will I regain?expand_more
STEP 1 data showed about two-thirds of weight loss returned within one year of stopping semaglutide — from 17.3% loss at week 68 to 5.6% net loss at week 120. Tirzepatide data from SURMOUNT-4 showed roughly half the loss returning over a year off therapy. Individual outcomes vary based on habits and biology.
Should I taper or stop cold turkey?expand_more
There is no formal taper protocol in the FDA labels. Many providers favor stepping down to a lower maintenance dose for some weeks before stopping entirely, which can soften the appetite rebound. This is a discussion to have with your prescriber, not a one-size-fits-all rule.
Will I get withdrawal symptoms?expand_more
GLP-1s are not addictive and there is no withdrawal syndrome. What you will likely notice is the return of pre-treatment appetite and food noise, which can feel jarring after months of suppression. That is not withdrawal — it is the absence of the drug's effect.
Can I restart later if I regain?expand_more
Yes, and many people do. The data on restarting after a break is broadly reassuring; most people regain responsiveness without issue. You typically restart at a lower titration dose and work back up, the same way you started the first time.

Keep exploring

Browse all GLP-1 guides.